|This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions are available. (November 2006)|
TCH346 is a drug currently in clinical trials that is used to help treat Amyotrophic Lateral Sclerosis (ALS). Though this drug is still in testing, it is felt to be a work in progres, and it is widely thought that it will be a great advancement in medical sciences.
- Neurological Institute of New York Columbia University
- National Center for Biotechnology Information articleTemplate:Pharma-stub